Remove 2019 Remove Clinical Practice Remove Individual Remove Provider
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Interpretation of Statutory Criteria Under the Final Guidance. Medical information about a patient.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

The Listening “EAR” approach that simplifies assessment of loneliness and social isolation in clinical settings, and other practical pointers. What it found is that healthcare providers are better at identifying people that are connected more than disconnected. I would say that. It’s tough.

IT 100
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Legalization is moving forward in several states , following the lead of Oregon and Colorado.

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. But, you know, I’ve talked to a lot of palliative care providers, a lot of people caring for people with serious illness. For those individuals, how do you think about that?

article thumbnail

Do statins reduce mortality in older people? Findings from a longitudinal study using primary care records

BMJ

A 20-year observational follow-up study of the clinical trial WOSCOPS (West of Scotland Coronary Prevention Study) made use of national mortality records and electronic health records to estimate the long-term survival effect of statins. 16 Figure 1. Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification.

article thumbnail

Episode 285: Anti-Racism in Medicine Series – Episode 21 – Psychosocial and Cultural Considerations for Providing Healthcare to Immigrant and Refugee Populations

The Clinical Problem Solvers

[link] CPSolvers: Antiracism in Medicine Series Episode 21 – Psychosocial and Cultural Considerations for Providing Healthcare to Immigrant and Refugee Populations Show Notes by Kiersten T. A lot of compounding trauma occurs at the border that has potential downstream mental health implications for individuals and their families.